HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.

Slides:



Advertisements
Similar presentations
Children and young people, injecting and HIV Under-18 and overlooked Young People and Injecting Drug Use: Overcoming barriers to HIV Prevention and Harmonizing.
Advertisements

Addressing the specific needs of women who inject drugs – a policy paper. Vienna. March 2014.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
2015 Kosovo HIV Concept Note CCM Meeting Discussion of the Draft 15 January 2015.
Needle and syringe programmes in prisons
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
Prison Reforms in Resource Poor Settings - South Asia Experience ICPA Conference Prague, 28 October 2008 Dr. Jayadev Sarangi, Prison Expert UNODC Regional.
Key Populations: Making Them Matter in the Global HIV Response Inextricable Links: HIV and Human Rights Kevin Osborne, LINKAGES Project Director 2 March.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
Lessons learned from Nairobi, and experiences from Serbia Mr.sci.prim.dr Dragan Ilić epidemiologist Република Србија МИНИСТАРСТВО ЗДРАВЉА 1.
European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.
Operational Approaches for Comprehensive Sex Worker Programmes An overview of Implementing Comprehensive HIV/STI Programmes with Sex Workers: Practical.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Presentation ‘Developing positive working relationships between Health and Law Enforcement Agencies’
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Dr Fabienne Hariga Senior Adviser UNODC HIV Section, Vienna 27 May 2014 Mandates, missions, roles and responsibilities & relation to health in prisons.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
EngenderHealth/UNFPA Project – Ethiopia/Ukraine Strengthening the integration of HIV prevention in maternal health services. Increasing the capacity of.
NACO and NACP. Response of Govt to HIV National AIDS Control Programme (NACP) under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999) NACP.
Treatment of drug addiction in prisons
Louisa Degenhardt 1, Bradley Mathers 1, Peter Vickerman 2, Tim Rhodes 3, Carl Latkin 4 and Matt Hickman 5 1.National Drug and Alcohol Research Centre,
Effective Drugs Policy and Harm Reduction in Tanzania
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
October 8, 2010 USAID Mini-University Clancy Broxton, MA, MPH Most At Risk Populations Advisor USAID Office of HIV/AIDS HIV Prevention for Most At- Risk.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Stemming the epidemics in prisons A shared responsibility Alice Quedraogo Director Programme on HIV and AIDS in the World of Work International Labour.
HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Epidemiological Impact and Cost Effectiveness of Harm Reduction Programmes in Russia Based on the results of the Global Fund Round 5 HIV Programme in Russia,
Essential package of targeted interventions for MARA Romania Experience.
Targeted Interventions for IDUs – an overview. Targeted Intervention for IDUs - an Overview 2 Background  In Asia, 4.7 million people were infected with.
Mobilizing for RH/HIV Integration Addis Ababa, Ethiopia Session on Technical Issues and Intersections Wednesday, February 26, 2008.
Prison Reforms - UNODC perspective Dr. Jayadev Sarangi, Prison Expert UNODC ROSA APCCA,2008 Langkawi, Malaysia, 24th November 2008.
Harm Reduction International
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
OVERVIEW ON CSO EFFORTS TO ADVOCATE FOR THE PROVISION OF SERVICES FOR PEOPLE WHO USE DRUGS IN UGANDA WAMALA TWAIBU Executive Director -UHRN
Knowing your Epidemic: Designing Better Interventions in Prisons Deputy Commissioner Mary C. Chepkonga Kenya Prisons Service International AIDS Conference.
Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: June 2015.
Effective HIV & SRH Responses Among Sex Workers and other Key Populations Module 2: A Comprehensive Package of Services for Key Populations.
Law Enforcement agencies and civil society organizations: critical partners in HIV services provision for people who use drugs Zhannat Kosmukhamedova,
33 MEETING OF THE UNAIDS PROGRAMME COORDINATING BOARD GENEVA, SWITZERLAND DECEMBER 2013 THE EQUITY DEFICIT: UNEQUAL AND UNFAIR ACCESS TO HIV TREATMENT,
EG HIV/AIDS & AI Internal Strategy and Action Plan Country priorities according to a survey in January-February 2014.
Universal Access Charter The Universal Access Charter is intended to be the voice of communities and civil societies around the world; The Charter is a.
Effective HIV & SRH Responses among Key Populations Module 2: A Comprehensive Package of Interventions for Key Populations.
Effective HIV & SRH Responses among Key Populations in Myanmar Module 2: The Core Package for Prevention of HIV amongst Key Populations in Myanmar.
MODULE 3 Harm reduction advocacy
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Cascade of care for people who use drugs - opportunities for integration and scale up of harm reduction services and other evidence based interventions.
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Addressing Drug Use Together Through a Health Based Approach:
People who inject drugs
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Towards a Conducive Legal and Structural Environment
Edward Mbizo Sibanda, (MSc) Right to Care
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
Myanmar Last Update: November 2014.
2025 AIDS targets Technical meeting on prevention
Presentation transcript:

HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna

Co-sponsor HIV among People who Use Drugs HIV in Prison Settings CONVENING AGENCY

Prevalence of HIV among people who inject drugs 12.7 million PWID (0.27 % ) 1.7 million PWID living with HIV (13.1% of PWID) 52% with hepatitis C Source: World Drug report 2014

HIV AND PEOPLE WHO INJECT DRUGS IN PRISONS

JOINT UN RECOMMENDED INTERVENTIONS Comprehensive Package of interventions for HIV prevention, treatment and care among people who inject drugs 1.Needle and syringe programmes (NSPs) 2.Opioid substitution therapy (OST) and other evidence-based drug dependence treatment 3.HIV testing and counselling (HTC) 4.Antiretroviral therapy (ART) 5.Prevention and treatment of sexually transmitted infections (STIs) 6.Condom programmes for people who inject drugs and their sexual partners 7.Targeted information, education and communication (IEC) for people who inject drugs and their sexual partners 8.Prevention, vaccination, diagnosis and treatment for viral hepatitis 9.Prevention, diagnosis and treatment of tuberculosis (TB).

Effectiveness of NSP  Reduction in the rate of HIV transmission (and HCV)  Frequency of unsafe injection (risk HIV and HCV)  No initiation of injecting among people who have not injected previously  No increase in the duration or frequency of illicit drug use or drug injection  Allow for IEC  Allow for referral to OST, HTC or ARV and TB  Reduce number of used syringes discarded in public areas  Bleach is not an effective alternative especially for Hepatitis C HIV (and hepatitis C or B) is transmitted among people who inject drugs through sharing injection equipment

 Opioid use  Frequency of injection & unsafe injection (risk HIV and HCV)  Risk of overdoses  Risk of abortion/miscarriage of pregnant opiate dependent women  Increase retention in drug dependence treatment  Adherence to treatment (ARV, TB, Hepatitis C)  Improve health status and wellbeing  Social functioning  Work and productivity and economic status  Criminal behaviour  Recidivism  Violence, drug seeking in prison Reduction in the rate of HIV transmission (and HCV) Effectiveness of OST

Why a comprehensive approach? Source: Sarkar et al, 2008

Universal Access Physically accessible – geographically distributed – Hard to reach location Affordable – patients should not have to pay for their treatment Equitable and non-discriminatory – no exclusion criteria except medical ones, e.g. – OST should not be limited to only those IDUs who are HIV infected or who have failed on other drug dependence treatment – No compulsory treatment Non-rationed – supply should be determined by need: – e.g. needle and syringe programmes with strict limits on the number of syringes provided to each client are less successful than those that do not impose such restrictions

HIV incidence Incidence du VIH à Maurice (2000-oct 2013) NSPNSP

PRINCIPLES  Prison health is public health  Linkages with public health and community programmes  Human rights based and gender sensitive  Principle of equivalence  Medical ethics  No segregation of PLWH;  Criminal justice reforms to reduce the prison population  Alternatives to imprisonment  Reduce pre-trial incarceration  End compulsory detention of drug users and sex workers for “rehabilitation”  Prison reforms  Ensure safe prison conditions  Prevent violence  Proper classification  Conjugal visiting rooms

12 Harm reduction in prisons

Bottlenecks

Critical enablers Supportive legal and policy framework Supportive law enforcement practices Empowerment of people who use drugs Alternatives to imprisonment including decriminalisation of drug use Appropriate funding

New publications: Police, HIV and PWID: a training manual Policy brief on HIV and women who inject drugs Handbook on needle and syringe programmes in prisons

…Unfortunately, many national drug control systems rely on sanctions and imprisonment, rather than evidence-based health care in full compliance with human rights standards … … These are major barriers to HIV and to harm reduction services, including in prisons and other closed settings… UNAIDS Programme Coordinating Board,1 July 2014

Thank you!